tiprankstipranks
Advertisement
Advertisement
Clearmind Medicine announces Hong Kong patent filing for depression therapy
PremiumThe FlyClearmind Medicine announces Hong Kong patent filing for depression therapy
19d ago
Psychedelic: Clearmind advances recruitment for CMND-100 trial’s third cohort
Premium
The Fly
Psychedelic: Clearmind advances recruitment for CMND-100 trial’s third cohort
20d ago
SciSparc’s Neurothera Labs announces publication of international patent
Premium
The Fly
SciSparc’s Neurothera Labs announces publication of international patent
20d ago
Psychedelic: Exclusive talk with nonprofit organization MAPS
PremiumThe FlyPsychedelic: Exclusive talk with nonprofit organization MAPS
1M ago
Clearmind Medicine files to sell 8.17M common shares for holders
Premium
The Fly
Clearmind Medicine files to sell 8.17M common shares for holders
1M ago
Psychedelic: Clearmind reports additional CMND-100 safety results
Premium
The Fly
Psychedelic: Clearmind reports additional CMND-100 safety results
2M ago
Clearmind Medicine welcomes inclusion of MEAI in bipartisan legislation
PremiumThe FlyClearmind Medicine welcomes inclusion of MEAI in bipartisan legislation
2M ago
Psychedelic: Clearmind completes second cohort treatment for CMND-100 trial
Premium
The Fly
Psychedelic: Clearmind completes second cohort treatment for CMND-100 trial
3M ago
Clearmind announces completion of treatment for second cohort in CMND-100 trial
Premium
The Fly
Clearmind announces completion of treatment for second cohort in CMND-100 trial
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100